232 related articles for article (PubMed ID: 35070024)
1. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies.
de Mattos ÂZ; Terra C; Farias AQ; Bittencourt PL;
World J Gastrointest Endosc; 2021 Dec; 13(12):628-637. PubMed ID: 35070024
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol
Dwinata M; Putera DD; Adda'i MF; Hidayat PN; Hasan I
World J Hepatol; 2019 May; 11(5):464-476. PubMed ID: 31183006
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
Shah HA; Azam Z; Rauf J; Abid S; Hamid S; Jafri W; Khalid A; Ismail FW; Parkash O; Subhan A; Munir SM
J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
[TBL] [Abstract][Full Text] [Related]
4. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.
Villanueva C; Sapena V; Lo GH; Seo YS; Shah HA; Singh V; Tripathi D; Schepke M; Gheorghe C; Bonilha DQ; Jutabha R; Wang HM; Rodrigues SG; Brujats A; Lee HA; Azam Z; Kumar P; Hayes PC; Sauerbruch T; Chen WC; Iacob S; Libera ED; Jensen DM; Alvarado E; Torres F; Bosch J;
Aliment Pharmacol Ther; 2024 Feb; 59(3):306-321. PubMed ID: 38108646
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers in liver cirrhosis.
Giannelli V; Lattanzi B; Thalheimer U; Merli M
Ann Gastroenterol; 2014; 27(1):20-26. PubMed ID: 24714633
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic treatment of esophageal varices in patients with liver cirrhosis.
Triantos C; Kalafateli M
World J Gastroenterol; 2014 Sep; 20(36):13015-26. PubMed ID: 25278695
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
Turco L; Reiberger T; Vitale G; La Mura V
Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.
Sarin SK; Wadhawan M; Agarwal SR; Tyagi P; Sharma BC
Am J Gastroenterol; 2005 Apr; 100(4):797-804. PubMed ID: 15784021
[TBL] [Abstract][Full Text] [Related]
10. The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis.
Yang J; Ge K; Chen L; Yang JL
Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1518-1526. PubMed ID: 31094853
[TBL] [Abstract][Full Text] [Related]
11. The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding.
Je D; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Clin Mol Hepatol; 2014 Sep; 20(3):283-90. PubMed ID: 25320732
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices.
Pérez-Ayuso RM; Valderrama S; Espinoza M; Rollán A; Sánchez R; Otarola F; Medina B; Riquelme A
Ann Hepatol; 2010; 9(1):15-22. PubMed ID: 20308718
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Oesophageal Varices in Liver Cirrhosis.
Sauerbruch T; Wong F
Digestion; 2019; 99(4):261-266. PubMed ID: 30212817
[TBL] [Abstract][Full Text] [Related]
14. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
Burza MA; Marschall HU; Napoleone L; Molinaro A
Pharmacol Res; 2017 May; 119():20-26. PubMed ID: 28099882
[TBL] [Abstract][Full Text] [Related]
15. Combined Pharmacological and Endoscopic Treatment for Worsening Gastroesophageal Varices in Patients with Cirrhosis.
Pepe V; Angeli P; Di Pascoli M
Clin Exp Gastroenterol; 2022; 15():59-65. PubMed ID: 35492075
[TBL] [Abstract][Full Text] [Related]
16. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
Zoller WG; Gross M
Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial.
De BK; Ghoshal UC; Das T; Santra A; Biswas PK
J Gastroenterol Hepatol; 1999 Mar; 14(3):220-4. PubMed ID: 10197489
[TBL] [Abstract][Full Text] [Related]
20. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis.
Yoo JJ; Kim SG; Kim YS; Lee B; Jeong SW; Jang JY; Lee SH; Kim HS; Jun BG; Kim YD; Cheon GJ
Medicine (Baltimore); 2020 Jan; 99(5):e18913. PubMed ID: 32000397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]